The present proposal requests renewal for UCLA's pre and post-doctoral Vascular Biology Training Program. Vascular disease remains the number one killer in the United States and many other developed countries. During the last three decades much attention has been placed in understanding the molecular and genetic basis of this pathology. These efforts have resulted in the development of novel drugs by the private sector that have significantly improved prevention, intervention and therapy of vascular disease. Nonetheless, the increased life-span of our population constantly brings new challenges that should be addressed. In addition, the need for targetted and more effective therapies with minimal side-effects continues and provides the impulse for the next decade of research in this area. Here at UCLA we have a tremendous resource of interdisciplinary investigators whose research focuses in vascular biology and constitute the basis for our training program. Now in its 4th year, the Vascular Biology Training Grant has trained 4 pre and 4 post doctoral fellows. In this short time, the trainees have collectively published 21 peer-reviewed manuscripts and secured positions in both academia and industry. Furthermore, the activities developed by the training program have propelled additional interactions between laboratories intensifying collaborative activies and co-mentorship of students. In this renewal we provide detail description of our progress and present a comprehensive training plan for the next five years. We seek funding for a total of 9 pre- and 3 post-doctoral fellows/year, in which 3 new pre- and either 1 or 2 new post-doctoral fellows will enter the program each year. This request is justified by the increased number of trainees in this area, which in the 2005 includes 82 pre- and 76 post-doctoral fellows working with our training faculty in the area of vascular biology. We have also increased our training mentors from 21 to 28 and developed one additional concentration area (Vascular Stem Cells). In addition, the training program has created an interactive plan with industry in which pre-doctoral fellows will spend three months working in biotechnology (at their site). The success of this training program has engendered enthusiasm by the School of Medicine, College of Letters and Sciences and the Graduate Division at UCLA all of which will directly support additional activities associated with our vascular program.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL069766-09
Application #
7844974
Study Section
Special Emphasis Panel (ZHL1-CSR-J (O1))
Program Officer
Commarato, Michael
Project Start
2002-04-01
Project End
2012-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
9
Fiscal Year
2010
Total Cost
$351,741
Indirect Cost
Name
University of California Los Angeles
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Ranjbarvaziri, Sara; Park, Shuin; Nguyen, Ngoc B et al. (2017) Generation of Nkx2-5/CreER transgenic mice for inducible Cre expression in developing hearts. Genesis 55:
Mack, Julia J; Mosqueiro, Thiago S; Archer, Brian J et al. (2017) NOTCH1 is a mechanosensor in adult arteries. Nat Commun 8:1620
Hu, Xuchen; Sleeman, Mark W; Miyashita, Kazuya et al. (2017) Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL. J Lipid Res 58:208-215
Rau, Christoph D; Vondriska, Thomas M (2017) DNA Methylation and Human Heart Failure: Mechanisms or Prognostics. Circulation 136:1545-1547
Allan, Christopher M; Larsson, Mikael; Jung, Rachel S et al. (2017) Mobility of ""HSPG-bound"" LPL explains how LPL is able to reach GPIHBP1 on capillaries. J Lipid Res 58:216-225
Hu, Xuchen; Dallinga-Thie, Geesje M; Hovingh, G Kees et al. (2017) GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia. J Clin Lipidol 11:964-971
Allan, Christopher M; Tran, Deanna; Tu, Yiping et al. (2017) A hypomorphic Egfr allele does not ameliorate the palmoplantar keratoderma caused by SLURP1 deficiency. Exp Dermatol 26:1134-1136
Rau, Christoph D; Romay, Milagros C; Tuteryan, Mary et al. (2017) Systems Genetics Approach Identifies Gene Pathways and Adamts2 as Drivers of Isoproterenol-Induced Cardiac Hypertrophy and Cardiomyopathy in Mice. Cell Syst 4:121-128.e4
Valenzuela, Nicole M; Thomas, Kimberly A; Mulder, Arend et al. (2017) Complement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003. Transplantation 101:1559-1572
Gao, Chen; Ren, Shuxun; Lee, Jae-Hyung et al. (2016) RBFox1-mediated RNA splicing regulates cardiac hypertrophy and heart failure. J Clin Invest 126:195-206

Showing the most recent 10 out of 113 publications